Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026

Invivyd (Nasdaq: IVVD) will host a webcast and conference call on May 14, 2026 at 8:30 a.m. ET to discuss first quarter 2026 financial results and provide a corporate update.

Rhea-AI Summary

Invivyd (Nasdaq: IVVD) will host a webcast and conference call on May 14, 2026 at 8:30 a.m. ET to discuss first quarter 2026 financial results and provide a corporate update. A replay will be available on the company investor website about two hours after the call.

Analysts may register to participate in the Q&A; attendees are advised to join 15 minutes early.

Argus May 7 session

-2.05% close to close Open Argus

Details

News Market Reaction – IVVD

On May 7, the day this news came out, IVVD closed 2.05% below the previous close.

Data tracked by StockTitan Argus for the May 7 session.

Market Context

This announcement schedules Invivyd’s Q1 2026 results call for May 14, 2026 at 8:30 a.m. ET, continu...

Analysis

This announcement schedules Invivyd’s Q1 2026 results call for May 14, 2026 at 8:30 a.m. ET, continuing a pattern where earnings serve as key catalysts. Recent updates have highlighted PEMGARDA revenue growth, narrowing losses, and progress of VYD2311 into pivotal trials. Investors may focus on revenue trends, cash levels, and pipeline timelines, alongside existing SEC disclosures that note going-concern risks and the company’s capacity to raise capital under its active shelf registration.

Key Figures

Earnings call date: May 14, 2026 Call time: 8:30 a.m. ET Replay availability: Approximately 2 hours after +1 more

Earnings call date

May 14, 2026

Scheduled Q1 2026 financial results and corporate update

Call time

8:30 a.m. ET

Start time for Q1 2026 conference call

Replay availability

Approximately 2 hours after

Webcast replay posted after call conclusion

Early join time

15 minutes prior

Advised login window before start of call

Previous Earnings Reports

5 past events · Latest: Nov 06

Same Type 5 events

1. Nov 06

   Q3 2025 earnings

   24h Move

   +1.3%

   Q3 2025 PEMGARDA growth, cash above $100M, pipeline progress for VYD2311.

2. Aug 14

   Q2 2025 earnings

   24h Move

   -11.5%

   Strong PEMGARDA revenue growth and positive VYD2311 Phase 1/2 data.

3. May 15

   Q1 2025 earnings

   24h Move

   -15.8%

   PEMGARDA revenue dip but improving net loss and sustained clinical progress.

4. Mar 20

   Q4/FY 2024 earnings

   24h Move

   +2.6%

   Q4 PEMGARDA growth to $13.8M and full-year revenue of $25.4M.

5. Feb 03

   Prelim Q4 2024

   24h Move

   +196.3%

   Preliminary Q4 revenue strength and sharply reduced operating costs toward profitability.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW HAVEN, Conn., May 07, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company focused on delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, May 14, 2026 at 8:30 a.m. ET to discuss its first quarter 2026 financial results and provide a corporate update.  

Interested parties can register for the webcast via this link. Analysts wishing to participate in the question-and-answer session should use this link. A replay of the webcast will be available via the company’s investor website approximately two hours after the call’s conclusion. Those who plan on participating are advised to join 15 minutes prior to the start time.

About Invivyd 

Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts: 
Media Relations 
(781) 208-0160 
media@invivyd.com 

Investor Relations 
(781) 208-1747 
investors@invivyd.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Invivyd (IVVD) release Q1 2026 results and host the earnings call?

Invivyd will host its Q1 2026 results call on May 14, 2026 at 8:30 a.m. ET. According to Invivyd, the webcast will cover first quarter financial results and a corporate update and will include a live Q&A session for analysts.

How can investors access the Invivyd (IVVD) May 14, 2026 webcast and replay?

Investors can register for the live webcast via the company’s investor website registration link. According to Invivyd, a replay will be posted on the investor website approximately two hours after the call concludes for later viewing.

Will analysts be able to ask questions during the Invivyd (IVVD) Q1 2026 call?

Yes. Analysts wishing to participate in the question-and-answer session should register using the designated analyst link. According to Invivyd, registered analysts will be able to join the live Q&A during the May 14 webcast after registering.

What time should participants join the Invivyd (IVVD) May 14, 2026 call?

Participants are advised to join the webcast 15 minutes prior to the 8:30 a.m. ET start. According to Invivyd, joining early helps ensure connection setup and timely participation in the live presentation and Q&A.

Where will the replay of Invivyd (IVVD) Q1 2026 conference call be available?

The replay will be available on Invivyd’s investor website about two hours after the call ends. According to Invivyd, the posted webcast replay allows investors and analysts to review the presentation and Q&A on demand.